Prognostic Value of Macrophage-Associated Long Non-Coding RNA Expression for Hepatocellular Carcinoma

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30. doi:10.3322/caac.21590
   PubMed Web of Science ®Google Scholar
• Wu J, Yang S, Xu K, et al. Patterns and trends of liver cancer incidence rates in Eastern and Southeastern Asian Countries (1983–2007) and predictions to 2030. Gastroenterology. 2018;154(6):1719–1728e5. doi:10.1053/j.gastro.2018.01.033
   PubMed Web of Science ®Google Scholar
• Yang L, Zhang Y. Tumor-associated macrophages, potential targets for cancer treatment. Biomark Res. 2017;5:25. doi:10.1186/s40364-017-0106-7
   PubMed Web of Science ®Google Scholar
• Allavena P, Sica A, Garlanda C, Mantovani A. The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance. Immunol Rev. 2008;222:155–161. doi:10.1111/j.1600-065X.2008.00607.x
   PubMed Web of Science ®Google Scholar
• Mantovani A, Locati M. Macrophage metabolism shapes angiogenesis in tumors. Cell Metab. 2016;24(5):653–654. doi:10.1016/j.cmet.2016.10.016
   PubMed Web of Science ®Google Scholar
• Daley D, Mani VR, Mohan N, et al. Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance. Nat Med. 2017;23(5):556–567. doi:10.1038/nm.4314
   PubMed Web of Science ®Google Scholar
• Guo X, Zhao Y, Yan H, et al. Single tumor-initiating cells evade immune clearance by recruiting type II macrophages. Genes Dev. 2017;31(3):247–259. doi:10.1101/gad.294348.116
   PubMed Web of Science ®Google Scholar
• Mantovani A, Marchesi F, Malesci A, Laghi L, Allavena P. Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol. 2017;14(7):399–416. doi:10.1038/nrclinonc.2016.217
   PubMed Web of Science ®Google Scholar
• Mahmoud SM, Lee AH, Paish EC, Macmillan RD, Ellis IO, Green AR. Tumour-infiltrating macrophages and clinical outcome in breast cancer. J Clin Pathol. 2012;65(2):159–163. doi:10.1136/jclinpath-2011-200355
   PubMed Web of Science ®Google Scholar
• Hu Y, He MY, Zhu LF, et al. Tumor-associated macrophages correlate with the clinicopathological features and poor outcomes via inducing epithelial to mesenchymal transition in oral squamous cell carcinoma. J Exp Clin Cancer Res. 2016;35:12. doi:10.1186/s13046-015-0281-z
   PubMed Web of Science ®Google Scholar
• Mello SS, Sinow C, Raj N, et al. Neat1 is a p53-inducible lincRNA essential for transformation suppression. Genes Dev. 2017;31(11):1095–1108. doi:10.1101/gad.284661.116
   PubMed Web of Science ®Google Scholar
• Durruthy-Durruthy J, Sebastiano V, Wossidlo M, et al. The primate-specific noncoding RNA HPAT5 regulates pluripotency during human preimplantation development and nuclear reprogramming. Nat Genet. 2016;48(1):44–52. doi:10.1038/ng.3449
   PubMed Web of Science ®Google Scholar
• Huarte M. The emerging role of lncRNAs in cancer. Nat Med. 2015;21(11):1253–1261. doi:10.1038/nm.3981
   PubMed Web of Science ®Google Scholar
• Leung A, Natarajan R. Long noncoding RNAs in diabetes and diabetic complications. Antioxid Redox Signal. 2018;29(11):1064–1073. doi:10.1089/ars.2017.7315
   PubMed Web of Science ®Google Scholar
• Schonrock N, Harvey RP, Mattick JS. Long noncoding RNAs in cardiac development and pathophysiology. Circ Res. 2012;111(10):1349–1362. doi:10.1161/circresaha.112.268953
   PubMed Web of Science ®Google Scholar
• Thum T. Noncoding RNAs and myocardial fibrosis. Nat Rev Cardiol. 2014;11(11):655–663. doi:10.1038/nrcardio.2014.125
   PubMed Web of Science ®Google Scholar
• Prensner JR, Chinnaiyan AM. The emergence of lncRNAs in cancer biology. Cancer Discov. 2011;1(5):391–407. doi:10.1158/2159-8290.CD-11-0209
   PubMed Web of Science ®Google Scholar
• Sun W, Yang Y, Xu C, Guo J. Regulatory mechanisms of long noncoding RNAs on gene expression in cancers. Cancer Genet. 2017;216–217:105–110. doi:10.1016/j.cancergen.2017.06.003
   PubMed Web of Science ®Google Scholar
• Luo HL, Chen J, Luo T, et al. Downregulation of macrophage-derived T-UCR uc.306 associates with poor prognosis in Hepatocellular carcinoma. Cell Physiol Biochem. 2017;42(4):1526–1539. doi:10.1159/000479269
   PubMedGoogle Scholar
• Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–2504. doi:10.1101/gr.1239303
   PubMed Web of Science ®Google Scholar
• Yu G, Wang LG, Han Y, He QY. ClusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284–287. doi:10.1089/omi.2011.0118
   PubMed Web of Science ®Google Scholar
• Walter W, Sánchez-Cabo F, Ricote M. GOplot: an R package for visually combining expression data with functional analysis. Bioinformatics. 2015;31(17):2912–2914. doi:10.1093/bioinformatics/btv300
   PubMed Web of Science ®Google Scholar
• Lee M, Ko H, Yun M. Cancer metabolism as a mechanism of treatment resistance and potential therapeutic target in Hepatocellular carcinsoma. Yonsei Med J. 2018;59(10):1143–1149. doi:10.3349/ymj.2018.59.10.1143
   PubMed Web of Science ®Google Scholar
• Sukowati CH, Rosso N, Crocè LS, Tiribelli C. Hepatic cancer stem cells and drug resistance: relevance in targeted therapies for hepatocellular carcinoma. World J Hepatol. 2010;2(3):114–126. doi:10.4254/wjh.v2.i3.114
   PubMedGoogle Scholar
• Wang N, Wang S, Li MY, et al. Cancer stem cells in hepatocellular carcinoma: an overview and promising therapeutic strategies. Ther Adv Med Oncol. 2018;10:1758835918816287. doi:10.1177/1758835918816287
   Web of Science ®Google Scholar
• Wang D, Bai T, Chen G, et al. Upregulation of long non-coding RNA FOXP4-AS1 and its regulatory network in hepatocellular carcinoma. Onco Targets Ther. 2019;12:7025–7038. doi:10.2147/OTT.S220923
   PubMed Web of Science ®Google Scholar
• Wang D, Du X, Bai T, et al. Decreased expression of long non-coding RNA GMDS Divergent Transcript (GMDS-DT) is a potential biomarker for poor prognosis of Hepatocellular carcinoma. Med Sci Monit. 2019;25:6221–6229. doi:10.12659/MSM.917663
   PubMed Web of Science ®Google Scholar
• Yu S, Li N, Wang J, et al. Correlation of long noncoding RNA SEMA6A-AS1 expression with clinical outcome in HBV-related Hepatocellular carcinoma. Clin Ther. 2020;42(3):439–447. doi:10.1016/j.clinthera.2020.01.012
   PubMed Web of Science ®Google Scholar
• Zaniani NR, Oroujalian A, Valipour A, Peymani M. LAMTOR5 expression level is a biomarker for colorectal cancer and lncRNA LAMTOR5-AS1 predicting miRNA sponging effect. Mol Biol Rep. 2021;48(8):6093–6101. doi:10.1007/s11033-021-06623-3
   PubMed Web of Science ®Google Scholar
• Jiang HY, Wang ZJ. ADPGK-AS1 promotes the progression of colorectal cancer via sponging miR-525 to upregulate FUT1. Eur Rev Med Pharmacol Sci. 2020;24(5):2380–2386. doi:10.26355/eurrev_202003_20505
   PubMed Web of Science ®Google Scholar
• Shuai S, Suzuki H, Diaz-Navarro A, et al. The U1 spliceosomal RNA is recurrently mutated in multiple cancers. Nature. 2019;574(7780):712–716. doi:10.1038/s41586-019-1651-z
   PubMed Web of Science ®Google Scholar
• Shi M, Dai WQ, Jia RR, et al. APC(CDC20)-mediated degradation of PHD3 stabilizes HIF-1a and promotes tumorigenesis in hepatocellular carcinoma. Cancer Lett. 2021;496:144–155. doi:10.1016/j.canlet.2020.10.011
   PubMed Web of Science ®Google Scholar
• Tellapuri S, Sutphin PD, Beg MS, Singal AG, Kalva SP. Staging systems of hepatocellular carcinoma: a review. Indian J Gastroenterol. 2018;37(6):481–491. doi:10.1007/s12664-018-0915-0
   PubMed Web of Science ®Google Scholar
• Chen ZH, Hong YF, Lin J, et al. Validation and ranking of seven staging systems of hepatocellular carcinoma. Oncol Lett. 2017;14(1):705–714. doi:10.3892/ol.2017.6222
   PubMed Web of Science ®Google Scholar
• Parikh ND, Scaglione S, Li Y, et al. A comparison of staging systems for Hepatocellular carcinoma in a multicenter US cohort. Clin Gastroenterol Hepatol. 2018;16(5):781–782. doi:10.1016/j.cgh.2017.10.001
   PubMed Web of Science ®Google Scholar
• Yang JD, Kim WR, Park KW, et al. Model to estimate survival in ambulatory patients with hepatocellular carcinoma. Hepatology. 2012;56(2):614–621. doi:10.1002/hep.25680
   PubMed Web of Science ®Google Scholar